BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6161177)

  • 1. Human helper T cell factor(s) (ThF). I. Partial purification and characterization.
    Hirano T; Teranishi T; Toba H; Sakaguchi N; Fukukawa T; Tsuyuguchi I
    J Immunol; 1981 Feb; 126(2):517-22. PubMed ID: 6161177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor- (TRF) like factor(s).
    Teranishi T; Hirano T; Arima N; Onoue K
    J Immunol; 1982 Apr; 128(4):1903-8. PubMed ID: 6801125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization.
    Jyonouchi H; Kimmel MD; Lee G; Kincade PW; Good RA
    J Immunol; 1985 Sep; 135(3):1891-9. PubMed ID: 3926891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
    Yoshizaki K; Nakagawa T; Kaieda T; Muraguchi A; Yamamura Y; Kishimoto T
    J Immunol; 1982 Mar; 128(3):1296-301. PubMed ID: 6799573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I).
    Hirano T; Teranishi T; Onoue K
    J Immunol; 1984 Jan; 132(1):229-34. PubMed ID: 6228579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
    Schwyzer M; Fontana A
    J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human helper T cell clone secreting both killer helper factor(s) and T cell-replacing factor(s).
    Kaieda T; Okada M; Yoshimura N; Kishimoto S; Yamamura Y; Kishimoto T
    J Immunol; 1982 Jul; 129(1):46-51. PubMed ID: 6177759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
    Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
    J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human helper T cell factor(s). IV. Demonstration of a human late-acting B cell differentiation factor acting on Staphylococcus aureus Cowan I-stimulated B cells.
    Hirano T; Teranishi T; Lin B; Onoue K
    J Immunol; 1984 Aug; 133(2):798-802. PubMed ID: 6234360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
    J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
    Butler JL; Ambrus JL; Fauci AS
    J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.
    Luben RA; Mundy GR; Trummel CL; Raisz LG
    J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and partial purification of human T lymphocyte colony-enhancing factor (LCEF), distinct from T cell-growth factor.
    Werber MM; Daphna D; Goldman J; Joseph D; Radnay J; Rozenszajn LA
    Immunology; 1983 Oct; 50(2):261-8. PubMed ID: 6604693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells from lymphoepithelial thymoma produce a biochemical variant of IL-2.
    Cornaglia-Ferraris P; Ponzoni M
    Lymphokine Res; 1985; 4(3):251-63. PubMed ID: 3875768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of a surface antigen expressed on activated human thymus-derived lymphocytes.
    Udey MC; Jendrisak MD; Parker CW
    J Immunol; 1982 Apr; 128(4):1870-5. PubMed ID: 6801123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of human B cell-activating factor.
    Wood DD
    J Immunol; 1979 Nov; 123(5):2395-9. PubMed ID: 39965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.